Veterinary Infectious Disease Diagnostics Market Size Report 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Veterinary Infectious Disease Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global veterinary infectious disease diagnostics market trends, share, size and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the veterinary infectious disease diagnostics market?

The global veterinary infectious disease diagnostics market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 8.6% during 2023-2028.

What is veterinary infectious disease diagnostics?

Veterinary infectious disease diagnostics refers to the field of veterinary medicine that focuses on the identification and detection of infectious diseases in animals. It involves the use of various diagnostic techniques and tools to determine the presence of pathogens, such as bacteria, viruses, parasites, or fungi, that can cause diseases in animals. These diagnostics methods may include laboratory tests, such as blood tests, microbiological cultures, serological assays, molecular diagnostics (PCR), imaging techniques, and histopathology. Accurate and timely diagnosis of infectious diseases in animals is crucial for effective treatment, disease management, prevention, and control, thereby promoting animal health and public health.

Request for a sample copy of this report: https://www.imarcgroup.com/veterinary-infectious-disease-diagnostics-market/requestsample

What are the growth prospects and trends in the veterinary infectious disease diagnostics industry?

The veterinary infectious disease diagnostics industry is experiencing significant growth prospects and witnessing notable trends. Firstly, there is an increasing awareness and emphasis on animal health, leading to higher demand for diagnostic tools and services. This trend is driven by the growing pet ownership and the expanding livestock industry, where effective disease management is crucial. Secondly, technological advancements have greatly improved the accuracy, speed, and accessibility of diagnostic methods. Innovations such as molecular diagnostics, point-of-care testing, and advanced imaging techniques are enhancing the capabilities of veterinarians to detect and diagnose infectious diseases more efficiently.

Additionally, the One Health approach, which recognizes the interconnectedness of human, animal, and environmental health, is gaining prominence. This approach underscores the need for robust infectious disease diagnostics in veterinary medicine, further driving market growth. Furthermore, the integration of artificial intelligence (AI) and data analytics into diagnostic platforms holds promise for more precise and personalized diagnostics, aiding in early disease detection and targeted treatment strategies.Overall, the veterinary infectious disease diagnostics industry is poised for continued growth due to increasing awareness, technological advancements, the One Health approach, and the integration of AI, all contributing to enhanced disease detection and management in animals.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Technology:

  • Immunodiagnostics
  • Molecular Diagnostics
  • Others

Breakup by Animal Type:

  • Companion Animals
  • Food Producing Animals

Breakup by Infection Type:

  • Bacterial Infections
  • Viral Infections
  • Parasitic Infections
  • Others

Breakup by End User:

  • Reference Laboratories
  • Veterinary Laboratories and Clinics
  • Point of Care/In House Testing
  • Research Institutes and Universities

Breakup by Region:

  • North America (U.S. & Canada)
  • Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
  • Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
  • Latin America (Brazil, Mexico)
  • Middle East & Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Abbott Laboratories
  • Biomérieux SA
  • Creative Diagnostics
  • HESKA Corporation
  • Innovative Diagnostics
  • IDEXX Laboratories Inc.
  • Neogen Corporation
  • Qiagen N.V.
  • Randox Laboratories Ltd
  • Thermo Fisher Scientific Inc

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4301&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: [email protected]

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Tags: